MedTrace Logo

Monitoring Allergen Immunotherapy in Allergic Rhinitis

NCT05621356 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2022-11-18

No results posted yet for this study

Summary

Allergic rhinitis (hay fever) can be treated successfully with allergen-specific immunotherapy (AIT) for 3-5 years. This relative expensive and prolonged treatment is not suitable for everyone and therefore it is important to predict who will benefit from this therapy early after the start of treatment.

This project will investigate whether a BAT with nasal fluid can detect inhibition during immunotherapy in comparison with a BAT with blood.

Conditions

  • Immunotherapy
  • Rhinitis, Allergic
  • Treatment Outcome

Interventions

OTHER

A nasal fluid Basophil Activation Test (BAT)

a BAT technique for monitoring the inhibitory effect of nasal fluid on basophil activation.

Sponsors & Collaborators

  • Wageningen University

    collaborator OTHER

  • Rijnstate Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-25
Primary Completion
2022-12-23
Completion
2023-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05621356 on ClinicalTrials.gov